Uracil Breath Test

Drug Profile

Uracil Breath Test

Alternative Names: 13C-Uracil breath test; C13-URA

Latest Information Update: 01 Jun 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Otsuka Pharmaceutical
  • Class Antineoplastics; Nitrogen mustard compounds; Pyrimidinones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Gastrointestinal motility disorders

Most Recent Events

  • 31 Dec 2015 Discontinued - Phase-II for Gastrointestinal motility disorders (Diagnosis) in USA (PO)
  • 30 Sep 2015 Phase-II clinical trials in Gastrointestinal motility disorders (Diagnosis) in USA (PO) before September 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top